MACROPHAGE PHARMA LIMITED is an immuno-oncology company established in 2014 with the slogan, "Empowering the immune system to combat cancer with precision-targeted therapies." Specializing in Biotechnology and Pharmaceutical industries, the company is dedicated to finding and developing new treatments to enhance anti-tumor immune responses. Macrophage Pharma's platform is designed to administer small molecule drugs directly to tumor-associated macrophages, thereby activating the body's natural immune system to fight against cancer. The company's most recent milestone was securing a £9.00M Series A investment on 09 January 2017 from prominent investors such as Novo Holdings, Aglaia Biomedical Ventures, MERL Ventures Fund, and SIXTH ELEMENT CAPITAL LLP.
MACROPHAGE PHARMA LIMITED
Empowering the immune system to combat cancer with precision-targeted therapies
General Information
BounceWatch is an independent company data service, not affiliated with MACROPHAGE PHARMA LIMITED. To contact MACROPHAGE PHARMA LIMITED, visit macrophagepharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MACROPHAGE PHARMA LIMITED compare?
A PDF of MACROPHAGE PHARMA LIMITED and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MACROPHAGE PHARMA LIMITED soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is MACROPHAGE PHARMA LIMITED on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About MACROPHAGE PHARMA LIMITED
Business keywords: immuno-oncology, cancer treatment, immune system, precision-targeted therapies, tumor-associated macrophages, small molecule drugs, treatment discovery, immune response activation, tumor therapy, novel therapies, immune system enhancement, anti-tumor immune responses, drug delivery technology, cancer research, biopharmaceutical company
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | £9.00M | 4 |
|
09 Jan 2017 |
MACROPHAGE PHARMA LIMITED Alternatives & Competitors
View All Alternatives
We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...
Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the...
Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...
FAQ About MACROPHAGE PHARMA LIMITED
Source: BounceWatch company record for MACROPHAGE PHARMA LIMITED, https://bouncewatch.com/company/macrophage-pharma, updated 27 December 2024. When citing, please name BounceWatch and link this page.
